All articles by Tania Rodrigues

How to democratize access and prevent the next supermodel medicine

"Supermodel" is not a term I was expecting to hear at this year's ISPOR Europe conference in Copenhagen, which had…
Dynamic reform in International Reference Pricing

The same week that we recently aired our webinar on the impact and risks of international reference pricing (IRP), Slovakia…
Barricading the front door: A look at Colombia’s moves toward value-based pricing

With Colombia having just launched controversial Decree 433 of 2018, which could penalize new innovative drugs upon market entry, value-based…
International Reference Pricing expands reach in leading Latin American countries

International reference pricing (IRP) is a common methodology adopted by developed markets to control drug prices; its use has also…
International reference pricing: Love it or hate it, there is a good way and a bad way to do it

Whilst at the Pharma Pricing & Market Access 2017 conference held recently in London, I had the opportunity to hear…

Hurdles encountered in transferability of health economic evidence to middle- and low-income countries

As more emerging economies seek to establish HTA agencies to inform pricing and reimbursement (P&R) decisions, I was curious to…
Two sides of the same coin: National health economic guidelines in Italy and Portugal

Whilst at ISPOR Vienna, I attended a lively session on national health economic guidelines in Southern Europe that highlighted how…
Proposed HTA agency AGNETS: The creation of a fourth hurdle in Argentina?

AGNET could be a new acronym that manufacturers will have to become acquainted with as a result of new Argentinean…
Through the comparative effectiveness research lens: US, European payers have a taste for real world trials

The US Patient-Centered Outcomes Research Institute (PCORI) celebrated the start of 2016 by putting comparative effectiveness research (CER) under the…
Inaction on hospital drug spending ruffles EC feathers as fresh political deadlock likely in Spain

In the wake of the political earthquake created by Brexit, the European Commission (EC) must be eagerly awaiting the formation…